Cancer Biomarkers Market Assessment, Trends Analysis and Competition Background during 2020 to 2025
Verfasser: ashwani_kailiya on Wednesday, 11 March 2020In a recent business intelligence study, FactMR presents the nitty-gritty of the global cancer biomarkers market considering 2015-2019 as the historic year and 2020–2025 as the stipulated time frame. The business report highlights the drivers, restraints, opportunities and trends affecting cancer biomarkers market growth. Further, all the market shares associated with the market as well as the segments are expressed in terms of value and volume.
Cancer accounts for 8.3 million deaths annually. Over the next two decades, 7 out of 10 patients are likely to suffer from this deadly disease. The increasing prevalence of cancer has facilitated extensive research in the diagnosis and treatment of cancer. Governments are increasingly funding clinical trials to assist companies in developing effective diagnostics and treatment for cancer. In April 2016, the National Cancer Institute (NCI) received a federal grant of US$ 5.2 Bn to aid it in its research. Aggressive funding initiatives by governments on cancer diagnostics are boosting the growth of the cancer biomarkers market.